Atlas Trials

Lingyi Biotech Co., Ltd.

3 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Lingyi Biotech Co., Ltd.

RecordFirmDate
A Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of Intracerebral Injection of LY-N001 Injection for the Treatment of Moderate to Advanced Parkinson's Disease With GBA1 Mutations (NCT07685444)Lingyi Biotech Co., Ltd.2026-07-07
Phase I/II Clinical Study to Evaluate the Safety, Tolerability and Efficacy of LY-M003 Injection in Adult Patients With Wilson's Disease (NCT07641140)Lingyi Biotech Co., Ltd.2026-06-15
A Clinical Study Evaluating LY-M001 Injection in the Treatment of Adult Patients With Type I Gaucher Disease (NCT06818838)Lingyi Biotech Co., Ltd.2024-07-05

Track Lingyi Biotech Co., Ltd. automatically

Every clearance here is in the API, with alerts when new ones post.